Aurinia Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AUPH and other ETFs, options, and stocks.About AUPH
Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.
CEOPeter S. Greenleaf
CEOPeter S. Greenleaf
Employees130
Employees130
HeadquartersEdmonton, Alberta
HeadquartersEdmonton, Alberta
Founded1993
Founded1993
Employees130
Employees130
AUPH Key Statistics
Market cap1.65B
Market cap1.65B
Price-Earnings ratio29.96
Price-Earnings ratio29.96
Dividend yield—
Dividend yield—
Average volume1.65M
Average volume1.65M
High today$12.86
High today$12.86
Low today$12.47
Low today$12.47
Open price$12.80
Open price$12.80
Volume1.19M
Volume1.19M
52 Week high$12.90
52 Week high$12.90
52 Week low$6.55
52 Week low$6.55
AUPH News
TipRanks 6d
Promising Drug Pipeline and Positive Trial Results Drive Buy Rating for Aurinia PharmaceuticalsIn a report released today, David Martin PhD from Bloom Burton maintained a Buy rating on Aurinia Pharmaceuticals, with a price target of $11.00. Elevate Your I...
Analyst ratings
86%
of 7 ratingsBuy
85.7%
Hold
14.3%
Sell
0%
People also own
Based on the portfolios of people who own AUPH. This list is generated using Robinhood data, and it’s not a recommendation.